Six people affected out of 7 million injected? Why would the authorities (CDC and FDA) even consider a halt for that minute level of extreme adverse reaction? Unless 1. one of those six was related to a "big wig", or 2. they know something else they aren't revealing.
From hard-left leaning MarketWatch.
https://www.marketwatch.com/story/federal-health-agencies-to-call-for-pause-in-use-of-jj-vaccine-over-blood-clotting-disorder-new-york-times-2021-04-13UPDATE: FDA and CDC call for pause in use of J&J vaccine over blood clotting disorderPublished: April 13, 2021 at 7:24 a.m. ET
By Ciara Linnane
The two leading federal public health agencies called for an immediate pause in the use of the Johnson & Johnson JNJ, -1.95% COVID-19 vaccine on Tuesday, after six recipients in the U.S. developed a rare disorder involving blood clots within six to 13 days after being vaccinated. The news was first reported by the New York Times, citing officials briefed on the decision. The U.S. Food and Drug Administration and Centers for Disease Control and Prevention said all six were women aged between 18 and 48 and emphasized that the adverse events appear to be "extremely rare." "In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia)," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research and Dr. Anne Schuchat, Principal Deputy Director of the CDC said in a statement. So far, nearly 7 million Americans have received J&J shots, and about 9 million more have been delivered to states, CDC data shows. Scientists from the FDA and CDC will jointly investigate possible links between the vaccine and the clotting disorder and determine whether it should continue to be used or be limited. An emergency meeting of the CDC's outside advisory committee has been scheduled for Wednesday. "Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution," said the statement. Regulators in Europe are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca PLC AZN, -0.85% AZN, -0.80% and Oxford University researchers. J&J shares slid 3.3% premarket, but are up 2.7% in the year to date through Monday, while the Dow Jones Industrial Average DJIA, -0.42% has gained 10.3%.